Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Dana E. Connors"'
Autor:
Ieuan Clay, Nele Peerenboom, Dana E Connors, Steven Bourke, Alison Keogh, Katarzyna Wac, Tova Gur-Arie, Justin Baker, Christopher Bull, Andrea Cereatti, Francesca Cormack, Damien Eggenspieler, Luca Foschini, Raluca Ganea, Peter MA Groenen, Nicole Gusset, Elena Izmailova, Christoph M Kanzler, Lada Leyens, Kate Lyden, Arne Mueller, Julian Nam, Wan-Fai Ng, David Nobbs, Foteini Orfaniotou, Thanneer Malai Perumal, Wojciech Piwko, Anja Ries, Alf Scotland, Nick Taptiklis, John Torous, Beatrix Vereijken, Shuai Xu, Laurenz Baltzer, Thorsten Vetter, Jörg Goldhahn, Steven C Hoffmann
Publikováno v:
Digital Biomarkers, Vol 7, Iss 1, Pp 28-44 (2023)
Background: Digital measures offer an unparalleled opportunity to create a more holistic picture of how people who are patients behave in their real-world environments, thereby establishing a better connection between patients, caregivers, and the cl
Externí odkaz:
https://doaj.org/article/8bfc22bc80e3453e82490bb1a5d5e323
Autor:
Shawn M. Sweeney, Hisham K. Hamadeh, Natalie Abrams, Stacey J. Adam, Sara Brenner, Dana E. Connors, Gerard J. Davis, Louis Fiore, Susan H. Gawel, Robert L. Grossman, Sean E. Hanlon, Karl Hsu, Gary J. Kelloff, Ilan R. Kirsch, Bill Louv, Deven McGraw, Frank Meng, Daniel Milgram, Robert S. Miller, Emily Morgan, Lata Mukundan, Thomas O'Brien, Paul Robbins, Eric H. Rubin, Wendy S. Rubinstein, Liz Salmi, Teilo Schaller, George Shi, Caroline C. Sigman, Sudhir Srivastava
Publikováno v:
Cancer Research. 83:1175-1182
Big data in healthcare can enable unprecedented understanding of diseases and their treatment, particularly in oncology. These data may include electronic health records, medical imaging, genomic sequencing, payor records, and data from pharmaceutica
Autor:
Shawn M. Sweeney, Hisham K. Hamadeh, Natalie Abrams, Stacey J. Adam, Sara Brenner, Dana E. Connors, Gerard J. Davis, Louis D. Fiore, Susan H. Gawel, Robert L. Grossman, Sean E. Hanlon, Karl Hsu, Gary J. Kelloff, Ilan R. Kirsch, Bill Louv, Deven McGraw, Frank Meng, Daniel Milgram, Robert S. Miller, Emily Morgan, Lata Mukundan, Thomas O'Brien, Paul Robbins, Eric H. Rubin, Wendy S. Rubinstein, Liz Salmi, Teilo H. Schaller, George Shi, Caroline C. Sigman, Sudhir Srivastava
Publikováno v:
Cancer Research. 83:1183-1190
The analysis of big healthcare data has enormous potential as a tool for advancing oncology drug development and patient treatment, particularly in the context of precision medicine. However, there are challenges in organizing, sharing, integrating,
Autor:
Laurent Dercle, Binsheng Zhao, Mithat Gönen, Chaya S. Moskowitz, Dana E. Connors, Hao Yang, Lin Lu, Diane Reidy-Lagunes, Tito Fojo, Sanja Karovic, Michael L. Maitland, Geoffrey R. Oxnard, Lawrence H. Schwartz
Publikováno v:
European Journal of Cancer. 161:138-147
Autor:
Robert T. McCormack, Daniel Stetson, Dana E. Connors, J. Carl Barrett, Kenneth D. Cole, Steven P. Lund, Chris Karlovich, Thomas Forbes, P. Mickey Williams, Megan H. Cleveland, Laura M. Yee, Christie J. Lau, Cloud P. Paweletz, Gary J. Kelloff, Benoit Destenaves, Hua-Jun He, Susan M. Keating
Publikováno v:
JCO Precision Oncology
PURPOSEWe report the results from a Foundation for the National Institutes of Health Biomarkers Consortium project to address the absence of well-validated quality control materials (QCMs) for circulating tumor DNA (ctDNA) testing. This absence is co
Autor:
Kenneth C. Anderson, Daniel Auclair, Stacey J. Adam, Amit Agarwal, Melissa Anderson, Hervé Avet-Loiseau, Mark Bustoros, Jessica Chapman, Dana E. Connors, Ajeeta Dash, Alessandra Di Bacco, Ling Du, Thierry Facon, Juan Flores-Montero, Francesca Gay, Irene M. Ghobrial, Nicole J. Gormley, Ira Gupta, Howard Higley, Jens Hillengass, Bindu Kanapuru, Dickran Kazandjian, Gary J. Kelloff, Ilan R. Kirsch, Brandon Kremer, Ola Landgren, Elizabeth Lightbody, Oliver C. Lomas, Sagar Lonial, María-Victoria Mateos, Rocio Montes de Oca, Lata Mukundan, Nikhil C. Munshi, Elizabeth K. O'Donnell, Alberto Orfao, Bruno Paiva, Reshma Patel, Trevor J. Pugh, Karthik Ramasamy, Jill Ray, Mikhail Roshal, Jeremy A. Ross, Caroline C. Sigman, Katie L. Thoren, Suzanne Trudel, Gary Ulaner, Nancy Valente, Brendan M. Weiss, Elena Zamagni, Shaji K. Kumar
Publikováno v:
Clinical Cancer Research. 27:5195-5212
The development of novel agents has transformed the treatment paradigm for multiple myeloma, with minimal residual disease (MRD) negativity now achievable across the entire disease spectrum. Bone marrow–based technologies to assess MRD, including a
Autor:
Dana E. Connors, Hao Yang, Geoffrey R. Oxnard, Caroline Robert, Gregory V. Goldmacher, Lawrence H. Schwartz, Richard D. Carvajal, Sanja Karovic, Michael L. Maitland, Ying Tang, Firas S. Ahmed, Laurent Dercle, Binsheng Zhao
Publikováno v:
Eur Radiol
To compare tumor best overall response (BOR) by RECIST 1.1 and iRECIST, to explore the incidence of pseudoprogression in melanoma treated with pembrolizumab, and to assess the impact of pseudoprogression on overall survival (OS). A total of 221 patie
Autor:
Laurent Dercle, Gary J. Kelloff, Lawrence H. Schwartz, Ying Tang, Patrick Hilden, Mithat Gonen, Dana E. Connors, Michael L. Maitland, Sanja Karovic, Chaya S. Moskowitz, Binsheng Zhao, Stacey J Adam, Geoffrey R. Oxnard
Publikováno v:
JCO Clinical Cancer Informatics. :1-12
Purpose To develop a public-private partnership to study the feasibility of a new approach in collecting and analyzing clinically annotated imaging data from landmark phase III trials in advanced solid tumors. Patients and Methods The collection of c
Autor:
Laurent Dercle, Binsheng Zhao, Mithat Gönen, Chaya S. Moskowitz, Ahmed Firas, Volkan Beylergil, Dana E. Connors, Hao Yang, Lin Lu, Tito Fojo, Richard Carvajal, Sanja Karovic, Michael L. Maitland, Gregory V. Goldmacher, Geoffrey R. Oxnard, Michael A. Postow, Lawrence H. Schwartz
Publikováno v:
JAMA Oncology. 8:385
Existing criteria to estimate the benefit of a therapy in patients with cancer rely almost exclusively on tumor size, an approach that was not designed to estimate survival benefit and is challenged by the unique properties of immunotherapy. More acc
Autor:
Lawrence H. Schwartz, Jessica Flynn, Ying Tang, Gary J. Kelloff, Binsheng Zhao, Julia Wilkerson, Sanja Karovic, Dana E. Connors, Laurent Dercle, Michael L. Maitland, Stacey J Adam, Geoffrey R. Oxnard, Firas S. Ahmed, Mengxi Zhou, Patrick Hilden, Tito Fojo, Mithat Gonen, Chaya S. Moskowitz
Publikováno v:
Clin Cancer Res
Purpose: Mathematical models combined with new imaging technologies could improve clinical oncology studies. To improve detection of therapeutic effect in patients with cancer, we assessed volumetric measurement of target lesions to estimate the rate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c8a1ea3e6f881895b08af2121d0428c
https://europepmc.org/articles/PMC8170504/
https://europepmc.org/articles/PMC8170504/